Overview

Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
To assess the pharamcodynamic effects of coadministrated SK3530(PDE5 inhibitor) and tamsulosin, phase I study in healthy volunteers was designed.
Phase:
Phase 1
Details
Lead Sponsor:
SK Chemicals Co., Ltd.
SK Chemicals Co.,Ltd.
Treatments:
Tamsulosin